Abstract
The role of exception points in outcomes of patients with fibrocystic liver-kidney disease: Implications for the National Liver Review Board.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Paper Title
Journal
Date
